Post by
biggerr on May 04, 2017 6:05pm
ARZ is upbeat on Zon
in its presentation for AGM, ARZ is saying that it expects 76% of formularies covering Zontivity which is higher than what Merck had. I wouldn't short ARZ before the earnings because there could be some good news about Zon. Whom do you trust more, the shorts or the company, ha
Comment by
biggerr on May 05, 2017 9:31am
The Zon will come out tomorrow So you gotta hang on 'til tomorrow, come what may! Tomorrow, tomorrow, I love ya, tomorrow...
Comment by
biggerr on May 05, 2017 1:22pm
Son of Zon will be victorious!
Comment by
kuatolives on May 06, 2017 11:07am
The shorts. They haven't been wrong once. The company hasn't been right once.
Comment by
biggerr on May 07, 2017 1:53pm
you know what they say, the previous history is not always an indicator of the future developments, you can't always judge a stock by what the company did in the past
Comment by
Floridas2000 on May 08, 2017 11:37am
Apparently tomorrow's numbers are going to be disgustingly bad judging by market pre-reaction to the news.
Comment by
kuatolives on May 08, 2017 11:46am
For the love of Vishnu, get out while there is something left. Reverse split is next.
Comment by
biggerr on May 08, 2017 2:06pm
Zon will make up for all the losses on Vimovo with 25 mil. potential patients who are MI/PAD/diabetic smokers like my aunt Edna
Comment by
biggerr on May 08, 2017 3:06pm
this stock gives me pain that no Vimovo can relief. BTW, Horizons sells Vimovo in the US and ARZ sells it outside of the US so even if Horizon reports lower US sales it doesn't mean it affects the ARZ sales of Vimovo, you dummies, ha
Comment by
kuatolives on May 08, 2017 3:22pm
$250M debt at 12% interest to Deerfield implies a $30M per annum cost of that loan, which is quickly approaching 1/2 of expected 2017 revenue alone. You can bet Deerfield is now shorting the hell out of this company to get its money back. Ya, dummies. ha
Comment by
biggerr on May 08, 2017 3:28pm
what about the $3 billion CXR debt and the stock is flying, ha
Comment by
kuatolives on May 08, 2017 3:34pm
CXR has lost 93% of its market cap in the last year. why do you keep saying "ha" at the end of your messages? Are you ok?
Comment by
biggerr on May 08, 2017 3:56pm
OK, I'll say hehehe now for all the idiots who sold today, ARZ will be 10% tomorrow if not more, hehehe
Comment by
biggerr on May 08, 2017 4:00pm
too bad ARZ doesn't sell drugs for idiocy, you guys could use some, hehehe
Comment by
GoldenDilemma on May 08, 2017 4:03pm
What about the guys who bought after the Q1 earnings? Or followed Adams' purchase? What do those guys need? Cuz, we're down over 50% since then...
Comment by
kuatolives on May 08, 2017 4:04pm
They've been trying to. They just can't get them approved by the FDA.